Hospitalization for serious blood and skin disorders following use of co-trimoxazole

British Journal of Clinical Pharmacology

Volumn 43, Issue 4, 1997, Pages 446-448

  Myers, Marian Wald ^a   Jick, Hershel ^a,b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b Boston Collab Drug Survlnc Program   (United States)

Author keywords

Adverse drug reactions; Blood disorders; Co trimoxazole; Skin disorders; Stvens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

COTRIMOXAZOLE;

ARTICLE; BLOOD TOXICITY; HOSPITALIZATION; HUMAN; PRIORITY JOURNAL; RISK FACTOR; SKIN TOXICITY;

EID: 8244232503     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00584.x     Document Type: Article

References (8)

1. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333: 1600-1607.
2. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-1285.
3. Keisu M, Wiholm BE, Palmblad J. Trimethoprim-sulfamethoxazole-associated blood dyscrasias. Ten years' experience of the Swedish spontaneous reporting system. J Int Med 1990; 228: 353-360.
4. Chan HL, Stern RS, Arndt KA, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Arch Dermatol 1990; 128: 43-47.
5. Jick H, Derby LE. A large population-based follow-up study of trimethoprim/sulfamethoxazole, trimethoprim, and cephalexin users for certain uncommon serious drug toxicity. Pharmacotherapy 1995; 15: 428-432.
6. Jick H, Watkins RN, Hunter JR, et al. Replacement estrogens and endometrial cancer. N Engl J Med 1979; 300: 218-222.
7. Jick H, Myers MW, Dean AD. Sulfasalazine and mesalazine associated blood disorders. Pharmacotherapy 1995; 15: 176-181.
8. Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328: 1670-1674.